Furthermore, the adverse effects of oral and subcutaneous semaglutide are comparable [27], offering a valuable alternative for patients and physicians who prefer oral medication as a more convenient route of administration in a primary care setting [27]
How the clinics get around the rules Doctors have always been allowed to supply unapproved products in special cases, through the Special Access Scheme and other lawful access pathways
Psychopharmacology, 210, 121-132
Instead, they suggest that switching therapies may represent a pragmatic strategy to maintain continuity of care when patients experience side effects, access issues, or other barriers
These sites also have fewer blood vessels, making injections easier and less painful